Graft failure after allogeneic hematopoietic stem cell transplantation

Area of Science:

• Hematology
• Immunology
• Transplantation Science

Background:

• Graft failure (GF) is a major complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT), impacting treatment success.
• Successful allo-HSCT relies on donor cell engraftment, which can be compromised by primary or secondary graft failure.
• Distinguishing between graft failure and poor graft function is crucial for understanding and managing these complications.

Purpose of the Study:

• To review current understanding of graft failure (GF) and poor graft function (PGF) in allo-HSCT.
• To elucidate the interactions between immune and hematopoietic compartments in GF and PGF.
• To summarize the pathophysiology, risk factors, and treatment strategies for GF and PGF.

Main Methods:

• Literature review of graft failure and poor graft function in allo-HSCT.
• Analysis of factors influencing graft engraftment and survival.
• Synthesis of current knowledge on immune-hematopoietic interactions.

Main Results:

• Graft failure encompasses primary (lack of engraftment) and secondary (loss of engraftment) forms.
• Identified risk factors for GF include HLA mismatch, disease status, conditioning regimen, stem cell dose, and ABO incompatibility.
• GF remains a significant obstacle despite various preventative and therapeutic approaches.

Conclusions:

• Graft failure and poor graft function are distinct entities requiring specific management.
• Understanding the underlying pathophysiology and risk factors is key to improving allo-HSCT outcomes.
• Further research and therapeutic advancements are needed to overcome graft failure as a complication of allo-HSCT.